Hematopoietic cytokines as tumor markers in gynecological malignancies: A multivariate analysis with ROC curve in endometrial cancer patients

Growth Factors

Volumn 30, Issue 1, 2012, Pages 29-36

  Ławicki, Sławomir ^a   Bedkowska, Grazyna Ewa ^a   Gacuta Szumarska, Ewa ^b   Szmitkowski, MacIej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Medical University   (Poland)

Author keywords

CA 125; Endometrial cancer; HGFs; Tumor markers

Indexed keywords

CA 125 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; STEM CELL FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER STAGING; CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY CANCER; ENDOMETRIUM CANCER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERUS MYOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; LEIOMYOMA; MACROPHAGE COLONY-STIMULATING FACTOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 84855849555     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2011.627332     Document Type: Article

References (42)

1. Asschert JGW, Vellenga E, Hollema H, van der Zee AGJ, de Vries EGE. 1997. Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1b(IL-1b), interlekin-11 (IL-11) and tumour necrosis factor-a (TNF-a) in p53-characterised human ovarian carcinomas. Eur J Cancer 33: 2246-2251.
2. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. 1991. Expression of the macrophage colonystimulating factor and its receptor in gynecologic malignancies. Cancer 67:990-996.
3. Baj G, Arnulfo A, Boldorini R, Nicosia G, Villa L, Malavasi F, Surico N. 2000. Hormonal modulation of GM-CSF receptor alpha-chain in in vitro models of endometrial cancer. Eur J Gynaecol Oncol 21:305-308. (Pubitemid 30468330)
4. Chao K, Chang C, Yen M, Wang P, Ng H. 1999. Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro. Gynecol Obstet Invest 48:280-284.
5. Elmore LW, Domson K, Moore JR, Kornstein M, Burks T. 2001. Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Arch Pathol Lab Med 125: 146-151. (Pubitemid 32096200)
6. Gadducci A, Cosio S, Capri A, Nicolini A, Genazzani AR. 2004. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother 58: 24-38. (Pubitemid 38117046)
7. Ginath S, Menczer J, Fintsi Y, Ben-Shem E, Glezerman M, Avinoach I. 2002. Tissue and serum CA 125 expression in endometrial cancer. Int J Gynecol Cancer 12:372-375. (Pubitemid 34839835)
8. Groblewska M, Mroczko B, Wereszczyńska-Siemiȩtkowska U, Myśliwiec P, Kȩdra B, Szmitkowski M. 2007. Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients. Clin Chem Lab Med 45:30-34. (Pubitemid 46155556)
9. Hirasawa K, Kitamura T, Oka T, Matsushita H. 2002. Bladder tumor producing granulocyte-colony stimulating factor and parathyroid hormone related protein. J Urol 167: 2130. (Pubitemid 34309684)
10. Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G. 1994. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 54:3049-3053. (Pubitemid 24187794)
11. Kamińska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Wojcik E, Chechlinska M, Steffen J. 2006. Pretreatment serum levels of cytokines and cytokine receptors in patients with nonsmall cell lung cancer, and correlations with clinicopathological features and prognosis. Oncology 70:115-125. (Pubitemid 43760337)
12. Kaściń ski B. 2002. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer Treat Res 107: 285-292.
13. Ławicki S.Bȩdkowska G.E.Gacuta-Szumarska E., Czygier M., Szmitkowski M. 2007 The plasma levels and diagnostics utility of stem cell factor and macrophage colony stimulating factor in endometrial cancer patientsrfsti Przegl Lek. 64 987-990
14. Ławicki S, Bȩdkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. 2009. The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri. Pol Merkur Lekarski 156: 609-615.
15. Ławicki S, Bȩdkowska GE, Gacuta-Szumarska E, Czygier M, Szmitkowski M. 2010. The plasma levels and diagnostics utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri. Pol Merkur Lekarski 167: 354-358.
16. Ławicki S, Bȩdkowska GE, Gacuta-Szumarska E, Knapp P, Szmitkowski M. 2008. The plasma levels and diagnostics utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients. Pol. Merkur. Lekarski. 25: 38-42
17. Ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M. 2006. The plasma levels and diagnostics utility of granulocyte-colony stimulating factor (G-CSF) and macrophage- colony stimulating factor (M-CSF) in ovarian cancer patients. Pol. Merkur. Lekarski. 125: 465-468. (Pubitemid 44875504)
18. Ławicki S, Czygier M, Omyła J, Bȩdkowska E, Szmitkowski M. 2007. The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients. Pol Merkur Lekarski 136: 259-262.
19. Ławicki S, Szmitkowski M, Wojtukiewicz M. 2006. The pretreatment plasma level and diagnostics utility of M-CSF in benign breast and breast cancer patients. Clin Chim Acta 371: 112-116.
20. Lockhart CJ, McVeigh GE, Harbinson MT. 2008. Elevated CA 125 and ascites: Not always malignancy. Ir J Med Sci 177: 63-66.
21. Mettler L, Salmassi A. 2005. Endometriosis and M-CSF receptor. Eur J Obstet. Gynecol. Reproduct Biol 123(Suppl.):S1-S66.
22. Milojkovic M, Hrgovic Z, Hrgovic I, JonatW, Maass N, Buković D. 2004. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet 269:176-180. (Pubitemid 38374704)
23. Miyasaka N. 2005. Introduction: Cytokine receptors and their classification. Nippon Rinsho 63(Suppl.):S5-S9.
24. Mroczko B, Groblewska M, Wereszczyńska-Siemiȩtkowska U, Kȩdra B, Konopko M, Szmitkowski M. 2006. The diagnostics value of G-CSF measurement in the sera of colorectal cancer and adenoma patients. Clin Chim Acta 371:143-147. (Pubitemid 44162909)
25. Mroczko B, Szmitkowski M, Wereszczyńska-Siemiȩtkowska U, Okulczyk B. 2005. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer. Dig Dis Sci 50:203-209.
26. Mroczko B, Wereszczyńska-Siemiȩtkowska U, Groblewska M, Łukaszewicz M, Szmitkowski M, Gryko M, Kedra B. 2006. The diagnostic value of hematopoietic cytokines measurement in the sera of gastric cancer and gastric ulcer patients. Clin Chim Acta 374:165-167. (Pubitemid 44572241)
27. Nasu K, Inoue C, Takai N, Kashima K, Miyakawa I. 2004. Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor. Obstet. Gynecol. 104:1086-1088. (Pubitemid 40458777)
28. Ohike N, Sato M, Hisayuki T, Imataka H, Sato S,Wada Y, Saito K, Takahashi M, Tajiri T, Kunimura T, Morohoshi T. 2007. Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors. Pathol Int 57:589-593. (Pubitemid 47222708)
29. Osuga Y, Koga K, Tsutsumi O, Igarashi T, Okagaki R, Takai Y, De Bruijn HW, Van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr 2000. Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis. Am J Reprod Immunol 44:231-235.
30. Parker WH. 2007. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87:725-736. (Pubitemid 46553757)
31. Punnonen R, Teisala K, Kuoppala T, Bennett B, Punnonen J. 1998. Cytokine production profiles in the peritoneal fluids of patients with malignanat or benign gynecologic tumors. Cancer 83:788-796. (Pubitemid 28387706)
32. Puride DM. 2003. Epidemiology of endometrial cancer. Rev Gynaecol Pract 3:217-220.
33. Rony AA, Horowitz IR, Tekmal RR. 1999. Serum levels of macrophage colony-stimulating factor-1 in cervical human papillomavirus infection and intraepithelial neoplasia. Am J Obstet. Gynecol. 180:28-32. (Pubitemid 29088384)
34. Savarese DM, Valiń ski H, Quesenberry P, Savarese T. 1998. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 34: 80-91. (Pubitemid 28080035)
35. Shizmu N, Miyatake R, Esa A. 2005. Squamous cell carcinoma of bladder producing granulocyte colony-stimulating factor (G-CSF): A case report. Acta Urol Jpn 51:121-124. (Pubitemid 40410384)
36. Sjovall K, Nilsson B, Einhorn N. 2002. The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol Oncol 85:175-178. (Pubitemid 34304030)
37. Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr. 2004. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colonystimulating factor using mixtures of multivariate normal distributions. J Clin Oncol 22:4059-4066. (Pubitemid 41185174)
38. Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. 1995. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1:313-325.
39. Suzuki M, Ohwada M, Sato L, Nagamoto M. 1995. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology 52:128-133.
40. Timmerman D, Van den Bosch T. 2005. Diagnostic strategies in endometrial cancer. Int Congress Ser 1279:141-148. (Pubitemid 43693442)
41. Uzan C, Cortez A, Dufournet C, Fauvet R, Siffroi J-P, Darai E. 2005. Endometrium from women with and without endometriosis, and peritoneal, ovarian and bowel endometriosis, show different c-kit protein expression. J Reprod Immunol 65: 55-63. (Pubitemid 40193401)
42. Van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F. 2011. HE4 and CA 125 as a diagnostic test in ovarian cancer: Prospective validation of the risk of ovarian malignancy algorithm. Br J Cancer 104:863-870.